Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

GCC hospital markets at a crossroads

Change is afoot for private hospital operators in the GCC with mandatory insurance rollouts and private sector-friendly reforms offset by squeezed margins and an exodus of foreign nationals. More big US non-profits have followed in the footsteps of their peers Cleveland and Mayo and investors are pouring money into new developments in some markets - but steering well clear of others. Here is our round-up after several weeks interviewing local sources for HBI Intelligence. 

Consortium buys German lab group amedes

German lab group amedes is selling to a consortium including Canada's OMERS Infrastructure, Goldman Sachs Asset Management, and asset manager AXA Investment Managers.

Interview: Giuseppe Recchi, CEO, Affidea

Europe’s largest imaging company Affidea wants to become a one-stop shop for all outpatient services. HBI talks to CEO Giuseppe Recchi about changing a brand’s reputation, a record year of M&A and how the pandemic impacted the business.

EMEA’s Top 100 largest groups by revenue revealed

HBI’s inaugural HBI Health Care Services Top 100 lists the largest 100 companies by EMEA health care services revenue. In total revenue their revenue came to over €105bn - and we've uncovered some surprising winners and losers. 

IVIRMA buys CREATE Fertility as it looks to expand abroad

Global reproductive specialist IVI RMA has acquired CREATE Fertility and low-cost specialist abc IVF in what it says is the UK's largest IVF deal. HBI speaks to Praful Nargund, CREATE's managing director, to find out more about its big plans for international expansion.

Icade Santé to IPO by year-end as Cofinimmo enters UK

French REIT Icade says it will float healthcare property investor Icade Santé by the end of 2021 to raise funds for a €3bn four-year investment plan. The news comes as Cofinimmo acquires its first healthcare assets in the UK.

Find Us